Please Wait
Applying Filters...
menu
    • menu
    FDA’s December 2025 OPOE list features 784 prescription drugs, 73 OTC drugs

    Data Compilation
    #PharmaFlow

    Pipeline Prospector 2025 highlights: FDA approves pill version of Novo’s Wegovy; BioMarin acquires Amicus for US$ 4.8 bn

    Stock Recap
    #PipelineProspector

    Menu

    Ammonium Glycyrrhizinate

    ACTIVE PHARMA INGREDIENTS

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 183Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name MF Registration No. Classification Initial Date of Reg. Latest Date of Reg. Registrant's Address
    29/01/2026 Maruzen Pharmaceuticals
    Japan
    		 Maruzen Pharmaceuticals Co., Ltd. 303MF10177 Monoammonium glycyrrhizinate 2021-12-09 2021-12-09 14703-10 Mukaihigashicho, Onomichi City, Hiroshima Prefecture
    29/01/2026 Maruzen Pharmaceuticals
    Japan
    		 Maruzen Pharmaceuticals Co., Ltd. 222MF10017 Monoammonium glycyrrhizinate 2010-01-07 2010-01-07 14703-10 Mukaihigashicho, Onomichi City, Hiroshima Prefecture
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.